Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling

Huaiyu Yang; Wei Dou; Jing Lou; Ying Leng; Jianhua Shen

doi:10.1016/j.bmcl.2008.01.020

Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling

Huaiyu Yang
, Wei Dou
, Jing Lou
, Ying Leng^*
, Jianhua Shen

^*此作品的通讯作者

CAS - Shanghai Institute of Materia Medica
East China University of Science and Technology

科研成果: 期刊稿件 › 文章 › 同行评审

44 引用（Scopus）

摘要

11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potential target for treatment of diabetes and metabolic syndrome. Docking and pharmacophore modeling have been used to discover novel inhibitors of 11β-HSD1. Several compounds, with large structural diversity and good potency against 11β-HSD1, have been found and their potency was determined by the enzyme assay. New scaffolds of 11β-HSD1 inhibitors are also reported.

源语言	英语
页（从-至）	1340-1345
页数	6
期刊	Bioorganic and Medicinal Chemistry Letters
卷	18
期	4
DOI	https://doi.org/10.1016/j.bmcl.2008.01.020
出版状态	已出版 - 15 2月 2008
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1016/j.bmcl.2008.01.020

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{598881f6a1014edeb3ef331c41f61ead,

title = "Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling",

abstract = "11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potential target for treatment of diabetes and metabolic syndrome. Docking and pharmacophore modeling have been used to discover novel inhibitors of 11β-HSD1. Several compounds, with large structural diversity and good potency against 11β-HSD1, have been found and their potency was determined by the enzyme assay. New scaffolds of 11β-HSD1 inhibitors are also reported.",

keywords = "11β-HSD1, 11β-HSD2, Docking, Inhibitor, Pharmacophore",

author = "Huaiyu Yang and Wei Dou and Jing Lou and Ying Leng and Jianhua Shen",

year = "2008",

month = feb,

day = "15",

doi = "10.1016/j.bmcl.2008.01.020",

language = "英语",

volume = "18",

pages = "1340--1345",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling

AU - Yang, Huaiyu

AU - Dou, Wei

AU - Lou, Jing

AU - Leng, Ying

AU - Shen, Jianhua

PY - 2008/2/15

Y1 - 2008/2/15

N2 - 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potential target for treatment of diabetes and metabolic syndrome. Docking and pharmacophore modeling have been used to discover novel inhibitors of 11β-HSD1. Several compounds, with large structural diversity and good potency against 11β-HSD1, have been found and their potency was determined by the enzyme assay. New scaffolds of 11β-HSD1 inhibitors are also reported.

AB - 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potential target for treatment of diabetes and metabolic syndrome. Docking and pharmacophore modeling have been used to discover novel inhibitors of 11β-HSD1. Several compounds, with large structural diversity and good potency against 11β-HSD1, have been found and their potency was determined by the enzyme assay. New scaffolds of 11β-HSD1 inhibitors are also reported.

KW - 11β-HSD1

KW - 11β-HSD2

KW - Docking

KW - Inhibitor

KW - Pharmacophore

UR - https://www.scopus.com/pages/publications/39049147112

U2 - 10.1016/j.bmcl.2008.01.020

DO - 10.1016/j.bmcl.2008.01.020

M3 - 文章

C2 - 18242087

AN - SCOPUS:39049147112

SN - 0960-894X

VL - 18

SP - 1340

EP - 1345

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 4

ER -

Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling

摘要

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此